New Emory initiatives drive innovation in the basic sciences
Research in the basic sciences traditionally has been a solitary enterprise.
Yet scientists recognize that challenging problems can be better addressed by teams that bring together researchers with complementary skills. For some time, Emory has been ahead of that curve, demonstrating the difference that a collaborative culture can make.
And it’s about to get even better.
Pillar Three of the One Emory strategic framework, “Innovation through Scholarship and Creative Expression,” includes a call to increase the impact of basic scientific research across the university.
The task force was co-chaired by Huw Davies, Asa Griggs Candler Professor of Chemistry, and Guido Silvestri, Georgia Research Alliance Eminent Scholar, interim chair of pathology and laboratory medicine and Yerkes National Primate Research Center director of microbiology and immunology. It comprised basic scientists from Emory College and the School of Medicine.
Emory has provided $5 million each to two priority research initiatives: “Biological Discovery through Chemical Innovation”, led by Davies and Haian Fu, associate dean of innovation and international strategies in the School of Medicine, chair of the Department of Pharmacology and Chemical Biology, and a research leader in the Winship Cancer Institute, and “From Molecular Pathogenesis to Global Pandemics”, led by Silvestri, Jaap de Roode and Ken Moberg. De Roode is associate professor of biology in Emory College and an expert in host-parasite interactions. Moberg is associate professor of cell biology in the School of Medicine.
Dr. Davies is a faculty member in the MSP program, Dr. Silvestri is an IMP faculty member, Dr. Fu is a faculty member in the CB and MSP programs, Dr. de Roode is a PBEE faculty member, and Dr. Moberg is a faculty member in the BCDB and GMB programs.
Click here to view the full story in the Emory News Center.